XML 26 R16.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS	6 Months Ended
SUBSEQUENT EVENTS	Jun. 30, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS On August 1, 2023, we acquired Delaware Diagnostic Imaging, P.A. for a purchase consideration of approximately $0.6 million. Delaware Diagnostic Imaging costs of a single multi modality radiology center located in Wilmington, Delaware. On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening. As part of the purchase agreement, we issued 18 months after acquisition, 113,303 shares of our common stock with an initial fair value at the date of close of $3.0 million subject to adjustment for any indemnification claims and will be adjusted to fair value in subsequent periods. On July 7, 2023, we settled the Stock Holdback contingent liabilities by issuing 113,303 shares of our common stock at an ascribed a value of $3.2 million.